Development of an enhanced health-economic model and cost-effectiveness analysis of tiotropium + olodaterol Respimat® fixed-dose combination for chronic obstructive pulmonary disease patients in Italy

C Selya-Hammer, NGR Guix, M Baldwin, A Ternouth, M Miravitlles, Maureen Rutten - van Molken, Lucas Goossens, Nasuh Buyukkaramikli, V Acciai

Research output: Contribution to journalArticleAcademicpeer-review

Original languageUndefined/Unknown
Pages (from-to)391-401
Number of pages11
JournalTherapeutic Advances in Respiratory Disease
Issue number5
Publication statusPublished - 2016

Cite this